[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc (HIMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,052,626
  • Shares Outstanding, K 231,458
  • Annual Sales, $ 2,348 M
  • Annual Income, $ 128,370 K
  • EBIT $ -31 M
  • EBITDA $ 26 M
  • 60-Month Beta 2.43
  • Price/Sales 2.50
  • Price/Cash Flow 30.33
  • Price/Book 13.12

Options Overview Details

View History
  • Implied Volatility 81.62% (+3.87%)
  • Historical Volatility 86.10%
  • IV Percentile 35%
  • IV Rank 32.78%
  • IV High 127.22% on 10/16/25
  • IV Low 59.38% on 12/31/25
  • Expected Move (DTE 6) 1.96 (7.51%)
  • Put/Call Vol Ratio 0.24
  • Today's Volume 229,430
  • Volume Avg (30-Day) 149,828
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 1,039,341
  • Open Int (30-Day) 1,096,631
  • Expected Range 24.19 to 28.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.01
  • Number of Estimates 5
  • High Estimate $0.15
  • Low Estimate $-0.16
  • Prior Year $0.17
  • Growth Rate Est. (year over year) -105.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.53 +21.46%
on 05/19/26
30.39 -13.94%
on 05/11/26
-0.18 (-0.68%)
since 04/29/26
3-Month
14.31 +82.74%
on 03/02/26
31.85 -17.91%
on 04/20/26
+11.63 (+80.10%)
since 02/27/26
52-Week
13.74 +90.32%
on 02/24/26
70.43 -62.87%
on 07/31/25
-27.19 (-50.97%)
since 05/28/25

Most Recent Stories

More News
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners

From connected fitness and cycle tracking to meal delivery and glucose monitoring, Hims & Hers subscribers now have ten ways to support their whole-body health

HIMS : 26.15 (+3.03%)
Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?

Hims & Hers is acquiring Australian telehealth platform Eucalyptus as part of its international expansion plan while using $350 million in convertible senior notes.

HIMS : 26.15 (+3.03%)
NVO : 45.58 (+0.15%)
LLY : 110.50 (-90.19%)
ABBV : 217.72 (-0.42%)
The Silver Lining of Last Week's Hims & Hers Earnings Miss

Hims & Hers plunged 23% after a major Q1 earnings miss, but long-term growth stays intact via its Novo Nordisk GLP-1 partnership and a late 2026 expansion.

HIMS : 26.15 (+3.03%)
NVO : 45.58 (+0.15%)
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets

EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:MMA),(NYSE:NVO),(NYSE:HIMS),(NYSE:LLY) EQNX::TICKER_END

MMA : 0.5402 (-0.57%)
BPC.CN : 0.4900 (-2.00%)
PNGAF : 0.3555 (-2.01%)
NVO : 45.58 (+0.15%)
HIMS : 26.15 (+3.03%)
LLY : 110.50 (-90.19%)
Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada

Personalised treatment plans pair medication with unlimited Care Team support, nutrition and lifestyle guidance, and Canadian medical expertise, starting at $149/month

HIMS : 26.15 (+3.03%)
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets

NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - The market for peptide-based health and performance products has been growing fast as more consumers focus on fitness,...

MMA : 0.5402 (-0.57%)
BPC.CN : 0.4900 (-2.00%)
PNGAF : 0.3555 (-2.01%)
NVO : 45.58 (+0.15%)
HIMS : 26.15 (+3.03%)
LLY : 110.50 (-90.19%)
Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide

By introducing access to generic semaglutide in Canada, the company is meeting the needs of a dynamic market and continuing its international expansion efforts

HIMS : 26.15 (+3.03%)
Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

Proceeds intended to be used to preserve financial flexibility as Hims & Hers executes on its international expansion strategy, including the proposed acquisition of Eucalyptus, invests in technology and...

HIMS : 26.15 (+3.03%)
Stocks Settle Mixed as Iran War Remains Unresolved

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.07%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.45%. June E-mini...

MSTR : 159.09 (+4.91%)
AMAT : 450.06 (+0.08%)
AVGO : 446.77 (+4.73%)
SNDK : 1,694.98 (+3.25%)
D : 66.94 (+0.34%)
HIMS : 26.15 (+3.03%)
MBLY : 10.34 (-0.67%)
GLXY : 29.58 (-1.83%)
$IUXX : 30,333.18 (+0.36%)
COIN : 189.03 (+3.72%)
ASML : 1,612.76 (+0.44%)
ZNU26 : 109-265s (+0.03%)
Stocks Pressured by a Rebound in Crude Prices and Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down -0.20%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.57%. June E-mini S&P futures...

MSTR : 159.09 (+4.91%)
AMAT : 450.06 (+0.08%)
AVGO : 446.77 (+4.73%)
SNDK : 1,694.98 (+3.25%)
D : 66.94 (+0.34%)
HIMS : 26.15 (+3.03%)
MBLY : 10.34 (-0.67%)
GLXY : 29.58 (-1.83%)
$IUXX : 30,333.18 (+0.36%)
COIN : 189.03 (+3.72%)
UNH : 380.31 (-0.58%)
ASML : 1,612.76 (+0.44%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Falling.

See More Share

Business Summary

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree...

See More

Key Turning Points

3rd Resistance Point 29.65
2nd Resistance Point 28.14
1st Resistance Point 27.15
Last Price 26.15
1st Support Level 24.64
2nd Support Level 23.13
3rd Support Level 22.14

See More

52-Week High 70.43
Fibonacci 61.8% 48.77
Fibonacci 50% 42.08
Fibonacci 38.2% 35.40
Last Price 26.15
52-Week Low 13.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.